Topoisomerase II−Drug Interaction Domains: Identification of Substituents on Etoposide That Interact with the Enzyme
Authors:
- Ryan P. BenderRBRyan P. Bender
- Murrell GodfreyMGMurrell Godfrey
- Sungjo ChoiSCSungjo Choi
- Clemens AnklinCAClemens Anklin
- David B. BerkowitzDBDavid B. Berkowitz
- Neil OsheroffNeil Osheroff
- David E. GravesDGDavid E. Graves
- 20 June 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 46 (28) , 8217-8225
Abstract
Etoposide is one of the most successful chemotherapeutic agents used for the treatment of human cancers. The drug kills cells by inhibiting the ability of topoisomerase II to ligate nucleic acids that it cleaves during the double-stranded DNA passage reaction. Etoposide is composed of a polycyclic ring system (rings A−D), a glycosidic moiety at the C4 position, and a pendent ring (E-ring) at the C1 position. Although drug−enzyme contacts, as opposed to drug−DNA interactions, mediate the entry of etoposide into the topoisomerase II−drug−DNA complex, the substituents on etoposide that interact with the enzyme have not been identified. Therefore, saturation transfer difference [1H]-nuclear magnetic resonance spectroscopy and protein−drug competition binding assays were employed to define the groups on etoposide that associate with yeast topoisomerase II and human topoisomerase IIα. Results indicate that the geminal protons of the A-ring, the H5 and H8 protons of the B-ring, and the H2‘ and H6‘ protons and the 3‘- and 5‘-methoxyl protons of the pendent E-ring interact with both enzymes in the binary protein−ligand complexes. In contrast, no significant nuclear Overhauser enhancement signals arising from the C-ring, the D-ring, or the C4 glycosidic moiety were observed with either enzyme, suggesting that there is limited or no contact between these portions of etoposide and topoisomerase II in the binary complex. The functional importance of E-ring substituents was confirmed by topoisomerase II-mediated DNA cleavage assays.Keywords
This publication has 51 references indexed in Scilit:
- DNA Topoisomerases: Structure, Function, and MechanismAnnual Review of Biochemistry, 2001
- Anticancer drug design based on plant-derived natural productsJournal of Biomedical Science, 1999
- Topoisomerase II and the Response to Antileukemic TherapyLeukemia & Lymphoma, 1998
- Spontaneous DNA Lesions Poison Human Topoisomerase IIα and Stimulate Cleavage Proximal to Leukemic 11q23 Chromosomal BreakpointsBiochemistry, 1997
- DNA topoisomerase II mutations and resistance to anti‐tumor drugsBioEssays, 1995
- A Yeast Type II Topoisomerase Selected for Resistance to QuinolonesJournal of Biological Chemistry, 1995
- Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase IIBiochemistry, 1991
- Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposideEuropean Journal of Cancer, 1990
- Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell lineBiochemistry, 1989
- Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationshipBiochemistry, 1984